Teneldim Sustained Release 10/750 mg

Adult dose

This medication is typically administered once daily with the evening meal, and dosage is adjusted in increments to reduce gastrointestinal side effects associated with metformin. The 20/1000 mg sustained release tablet is taken once daily, one tablet at a time. Patients taking 10/750 mg or 10/500 mg sustained release tablets should take two tablets at the same time once daily. The initial dosage consists of teneligliptin 20 mg once daily and metformin.

This drug is used to assist with blood sugar control, but it can rarely cause a serious condition called lactic acidosis, which requires caution. Lactic acidosis risk may increase in patients with reduced kidney function or poor heart and liver health. Additionally, hypoglycemia may occur when taken with insulin or other diabetes medications, so blood sugar levels should be closely monitored. This drug should not be used in patients with moderate to severe renal impairment or in those with heart failure or acute myocardial infarction. If iodinated contrast media used in radiological tests is received, this medication should be stopped 48 hours before the test and resumed only after confirming normal kidney function. It is also safer for pregnant women or those who could become pregnant, as well as patients with severe liver impairment, not to take this medication. During treatment with this drug, gastrointestinal disturbances, liver function abnormalities, acute pancreatitis, and skin rashes may occur; any unusual symptoms should be reported to a doctor immediately. The elderly may experience decreased kidney function, so regular kidney function tests should be conducted and dosage adjustments may be necessary. In case of overdose, appropriate treatment should be sought at a hospital, and especially in patients with poor kidney function, hemodialysis may be required. Alcohol consumption during treatment should be avoided, and understanding the symptoms of hypoglycemia and how to respond to them is essential. Moreover, other medications may interact with this drug, so patients must inform medical personnel of any medications they are taking. Breastfeeding women are advised to avoid this medication and should consult with a doctor to decide on whether to discontinue breastfeeding if necessary. The safety of this drug in pediatric patients has not been established, and it should not be used in children. Regular blood tests and physical examinations are important for monitoring health status during treatment with this drug.

Serious side effects

Hives, severe swelling, difficulty breathing, cold sweat, chest tightness, liver dysfunction (jaundice), acute pancreatitis, blistering Dermatitis herpetiformis, interstitial pneumonia, severe allergic reactions, respiratory distress, severe swelling accompanied by elevated blood pressure, hypoglycemia, severe lactic acidosis, confusional state, elevated blood pressure, cerebral infarction, hepatic coma, severe neurologic symptoms, seizures, paralysis, visual disturbances, severe hypoglycemia, severe joint pain, and kidney dysfunction.

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• headache
• nausea
• abdominal pain
• diarrhea
• decreased appetite
• itching
• allergic dermatitis

This drug should be stored in a tightly closed container to prevent exposure to air, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness.

Appearance

Yellow, oval-shaped sustained release film-coated tablets

Package unit

30 tablets/bottle